Shares in UK drugs giants GlaxoSmithKline plc. (LON:GSK), AstraZeneca PLC (LON:AZN) and Shire Plc. (LON:SHP) made large gains on Thursday following the release of the Senate Republicans’ healthcare plan.
The bill aims to repeal and replace Obamacare, with deep cuts to Medicaid funding and the re-shaping of subsidies to low-income people for private insurance.
Analysts suggested that the new bill – which is set to be put to a vote before the 4 July break – could be more beneficial to big pharma than originally expected. Healthcare stocks were also one of the best performers earlier this week on high hopes for eased regulations in the industry.
Disclaimer: The opinions expressed by our writers are their own and do not represent the views of Getting Money Wise. The information provided on Getting Money Wise is intended for informational purposes only. Getting Money Wise is not liable for any financial losses incurred. Conduct your own research by contacting financial experts before making any investment decisions.